Efaproxiral-d6 structure
|
Common Name | Efaproxiral-d6 | ||
---|---|---|---|---|
CAS Number | 1246815-16-6 | Molecular Weight | 347.44 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C20H17D6NO4 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of Efaproxiral-d6Efaproxiral-d6 (RSR13-d6) is the deuterium labeled Efaproxiral. Efaproxiral (RSR13) is a haemoglobin (Hb) synthetic allosteric modifier, decreases Hb-oxygen (O2) binding affinity and enhances oxygenation of hypoxic tumours during radiation therapy[1][2]. |
Name | Efaproxiral-d6 |
---|
Description | Efaproxiral-d6 (RSR13-d6) is the deuterium labeled Efaproxiral. Efaproxiral (RSR13) is a haemoglobin (Hb) synthetic allosteric modifier, decreases Hb-oxygen (O2) binding affinity and enhances oxygenation of hypoxic tumours during radiation therapy[1][2]. |
---|---|
Related Catalog | |
In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1]. |
References |
Molecular Formula | C20H17D6NO4 |
---|---|
Molecular Weight | 347.44 |